Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 6Phase 3 4Phase 1/2 3Phase 1 2Phase 2/3 1

Status

Completed 15Active not recruiting 4Unknown 3Recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Uterine Cervical Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 119Specimen Handling 104pembrolizumab 102Magnetic Resonance Spectroscopy 96fludarabine 92Biopsy 79Injections 53Nivolumab 41venetoclax 40Bevacizumab 40Fluorouracil 38Paclitaxel 37Cisplatin 36Cetuximab 35Carboplatin 35Gemcitabine 31fludarabine phosphate 30Radiotherapy 30Oxaliplatin 30Leucovorin 28Immunotherapy, Adoptive 25Drug Therapy 25Ipilimumab 24Azacitidine 23Irinotecan 21130-nm albumin-bound paclitaxel 21tislelizumab 20Temozolomide 20Radiation 20atezolizumab 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Recruiting × Brachytherapy × Clear all
NCT05570422 2026-04-08

A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01

Kortuc, Inc.

Phase 1 Recruiting
70 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT04473781 2026-03-02

Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer

Jonsson Comprehensive Cancer Center

Phase 1 Recruiting
17 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡